Quick Summary: Choosing the right CRISPR lateral flow strip OEM partner for your IVD or POCT brand requires evaluating label compatibility, strip format, lyophilization capability, regulatory documentation, OEM packaging flexibility, and supply consistency. This guide presents an evaluation checklist used by global IVD distributors and diagnostic developers in 2026, with reference to TiosBio’s LF-detect Cas12/13 family (JY0301, JY0307, JY0308) as a worked example.
Why CRISPR LFA strip OEM is now a strategic decision
Distributors that historically focused on antigen rapid tests are increasingly being asked by hospitals, reference labs, and ministries of health for CRISPR-based detection panels for HPV typing, antimicrobial resistance markers, sexually transmitted infections, and respiratory viruses. Most distributors do not manufacture strips themselves and instead source CRISPR LFA strips from OEM partners. Choosing the wrong OEM partner creates supply gaps, regulatory rework, and brand exposure. This article provides a structured 8-point evaluation checklist.
The 8-point CRISPR LFA OEM evaluation checklist
1. Label compatibility with your assay design
CRISPR Cas12/Cas13 reporters are typically labeled with Biotin–FAM, Biotin–FITC, Biotin–TAMRA, or Biotin–Digoxigenin. Confirm that the OEM strip uses antibody capture lines compatible with your reporter labels. TiosBio’s JY0301 Cas12/13 Dedicated Strips support Biotin + FITC / 6-FAM as the default label combination, with Digoxin/TAMRA available on the JY0209 Universal Dual-Labeled platform.
2. Strip format: single-target vs dual-target vs multiplex
| Format | Targets per strip | Use case | TiosBio reference |
|---|---|---|---|
| Single-target | 1 | Single-pathogen confirmation | JY0201, JY0301 |
| Dual-target (single Cas) | 2 | Pathogen + control, or two strains | JY0307 |
| Dual-target (Cas12 + Cas13) | 2 (DNA + RNA) | Mixed DNA + RNA panels (e.g., resistance gene + virus) | JY0308 |
| 3-Plex | 3 | Syndromic respiratory or STI panels | JY0230 |
3. Lot-to-lot consistency
Ask the OEM partner for documented lot-to-lot performance data covering at least 3 consecutive production lots. Acceptable variation in test-line intensity should be ≤ 15% by densitometry. TiosBio publishes lot-to-lot performance documentation on request as part of OEM/ODM technical packages.
4. Lyophilization and dry-reagent integration
For cartridge-integrated POC platforms, the OEM partner needs to support lyophilization of the amplification step (and ideally the Cas reaction). RPApex Basic (JY0800) ships as lyophilized pellets at 48 reactions/kit and integrates cleanly with cartridge-based platforms.
5. Storage and stability
- Strips: Room temperature 18–28 °C, 12 months minimum shelf life.
- RPApex pellets: 12 months at –20 °C; growing demand for room-temperature-stable pellet formats.
- Sample release reagents: BT0066 at –20 °C, BT0068/BT0069 at room temperature.
6. OEM packaging and regulatory flexibility
For distributor-led IVD registration, you need:
- Private-label packaging (your brand on the pouch and outer carton).
- Country-specific language and IFU (instructions for use) localization.
- Manufacturer name and address handling for regulatory submission (with declaration support).
- Stability data, performance evaluation reports, and biocompatibility documentation.
7. Quality system and certifications
Confirm the OEM partner’s quality management system (ISO 13485-style for IVD-grade lines), GMP practices for manufacturing-grade output, and willingness to accept third-party audits. Request the QMS scope letter and most recent certificate.
8. Supply chain and lead time
- Standard lead time for catalogue items: 2–4 weeks.
- OEM private-label runs: 6–10 weeks for first lot, 4–6 weeks for follow-on lots.
- Minimum order quantity (MOQ): typically 1,000–5,000 strips for OEM private label.
- Inventory buffer: confirm the OEM holds finished-goods or component stock to absorb demand spikes.
Documentation package to request before signing
- Catalogue datasheets for each product (JY0301, JY0307, JY0308, JY0201, JY0230 as relevant).
- Stability and shelf-life report.
- Lot-to-lot performance summary.
- Certificate of Analysis (CoA) template.
- QMS certificate scope (ISO 13485 if applicable).
- Sample IFU and label artwork files for OEM customization.
- List of registered markets where similar products are already in distribution.
Red flags to watch
- Unwilling to share lot-to-lot data.
- No documented stability beyond 6 months.
- Refusal to support private-label packaging.
- No clear position on third-party audit access.
- Pricing that is unusually low compared to documented BOM (often signals quality risk).
- Absent or generic IFU files.
Frequently Asked Questions
What is the typical MOQ for CRISPR lateral flow OEM?
Typical MOQ ranges from 1,000 to 5,000 strips per private-label run, depending on customization scope. Catalogue products such as TiosBio JY0301 are available in 50 strips/tube units without MOQ.
Can the OEM partner help with regulatory registration in my market?
Most CRISPR LFA OEM partners provide technical files and supporting documentation. Local registration is typically led by the distributor or the customer’s local entity. TiosBio supplies technical documentation and declaration letters to support OEM customer registration.
Does the OEM provide guide RNA design and assay-specific development?
Yes. ODM (Original Design Manufacturer) services include guide RNA design, primer design for the upstream amplification, and validation against target sequences. Catalogue OEM (private-label) does not include assay design — only packaging customization.
How do I evaluate strip quality during sample testing?
Run a positive control, a negative control, and a panel of clinical samples covering the expected analytical range. Score test-line intensity by densitometry and check for non-specific binding, control-line consistency, and background. Repeat across 3 lots before committing to an OEM contract.
Conclusion
Choosing a CRISPR lateral flow strip OEM is a long-term portfolio decision. Run all 8 checklist points before signing. TiosBio’s LF-detect Cas12/13 family (JY0301, JY0307, JY0308) combined with RPApex isothermal amplification (JY0800, JY0808) and sample-release reagents (BT0066, BT0068) covers the end-to-end workflow most distributors need. Contact us to request the OEM/ODM technical package and pricing structure.